Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides

被引：0
|
作者：
Lim, J. C. [1 ]
Cho, E. H. [1 ]
Lee, S. Y. [1 ]
Dho, S. H. [1 ]
Kim, S. Y. [1 ]
Jung, S. H. [1 ]
机构：
[1] Korea Atom Energy Res Inst, Daejeon, South Korea
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
Theranosis; Prostate cancer; Bombesin; Radionuclide;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [41] Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
    Wurzer, Alexander
    De Rose, Francesco
    Fischer, Sebastian
    Schwaiger, Markus
    Weber, Wolfgang
    Nekolla, Stephan
    Wester, Hans-Juergen
    Eiber, Matthias
    D'Alessandria, Calogero
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2024, 9 (01)
  • [42] 68Ga/177Lu-NeoBOMB1, A Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology (vol 58, pg 293, 2017)
    Dalm
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (07) : 1164 - 1164
  • [43] The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
    Scarpa, Lorenza
    Buxbaum, Sabine
    Kendler, Dorota
    Fink, Katharina
    Bektic, Jasmin
    Gruber, Leonhard
    Decristoforo, Clemens
    Uprimny, Christian
    Lukas, Peter
    Horninger, Wolfgang
    Virgolini, Irene
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (05) : 788 - 800
  • [44] The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates
    Lorenza Scarpa
    Sabine Buxbaum
    Dorota Kendler
    Katharina Fink
    Jasmin Bektic
    Leonhard Gruber
    Clemens Decristoforo
    Christian Uprimny
    Peter Lukas
    Wolfgang Horninger
    Irene Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 788 - 800
  • [45] Preclinical Investigations to Explore the Difference between the Diastereomers [177Lu]Lu-SibuDAB and [177Lu]Lu-RibuDAB toward Prostate Cancer Therapy
    Borgna, Francesca
    Deberle, Luisa M.
    Busslinger, Sarah D.
    Tschan, Viviane J.
    Walde, Laura M.
    Becker, Anna E.
    Schibli, Roger
    Mueller, Cristina
    MOLECULAR PHARMACEUTICS, 2022, : 2105 - 2114
  • [46] Development and Evaluation of Novel 68Ga/177Lu-Labeled PSMA Inhibitors with Enhanced Pharmacokinetics and Tumor Imaging for Prostate Cancer
    Li, Haiyang
    Liu, Yang
    Yuan, Hongmei
    Cai, Ping
    Wu, Tongtong
    Yang, Zhicong
    Nie, Jiaqi
    Zhang, Wei
    Huang, Zhanwen
    Liu, Nan
    Chen, Yue
    Zhou, Zhijun
    MOLECULAR PHARMACEUTICS, 2025, 22 (03) : 1584 - 1597
  • [47] Dansylated Amino Acid Derived 68Ga/177Lu-LNC1011 as Prostate Cancer Theranostics
    Yang, H.
    Wen, X.
    Guo, H.
    Zhang, J.
    Zhou, Z.
    Chen, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S9 - S9
  • [48] [68Ga]Ga/[177Lu]Lu-AAZTA-NI-FAPI-04: a new improved FAP-targeting agent containing nitroimidazole moiety for diagnosis and radiotherapy
    Luo, Y.
    Jin, W.
    Hong, H.
    Huang, Y.
    Yan, L.
    Wang, R.
    Qiao, J.
    Zhu, L.
    Kung, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S96 - S97
  • [49] The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry
    Azadeh Akhavanallaf
    Avery B. Peterson
    Kellen Fitzpatrick
    Molly Roseland
    Ka Kit Wong
    Issam El-Naqa
    Habib Zaidi
    Yuni K. Dewaraja
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 2984 - 2996
  • [50] The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
    Simsek, Duygu Has
    Guzel, Yunus
    Denizmen, Dilara
    Sanli, Yasemin
    Buyukkaya, Fikret
    Kovan, Bilal
    Komek, Halil
    Isik, Emine Goknur
    Ozkan, Zeynep Gozde
    Kuyumcu, Serkan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (03) : 828 - 840
12345